LABEL Act
HR 5969, the LABEL Act, requires abortion-inducing drugs to include specific labeling identifying both the drug dispenser's name/address and the prescriber's name. It directly affects pharmacies, clinics, and prescribers distributing these drugs by mandating this labeling on all such products. The bill prohibits states from imposing stricter labeling rules than this federal standard. It defines "abortion-inducing drug" as one intended or used to end a pregnancy (excluding drugs for miscarriage management or ectopic pregnancy treatment). This is a labeling requirement, not a restriction on drug access or use.
Bill status
in committee
1 of 4 stages cleared
Introduction
Nov 2025
Committee Review
Floor Vote
President
Introduced Nov 7, 2025
Last action Nov 7, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Nov 7, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Nov 7, 2025
Introduced
Introduced in House
lower
1 primary · 15 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Barry Moore
RRepublican
Co
Andrew S. Clyde
RRepublican
Co
Andy Harris
RRepublican
Co
August Pfluger
RRepublican
Co
Gary J. Palmer
RRepublican
Co
Harriet M. Hageman
RRepublican
Co
John J. McGuire III
RRepublican
Co
Mark Harris
RRepublican
Co
Mary E. Miller
RRepublican
Co
Michael Guest
RRepublican
Co
Mike Bost
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 5969
Scope: US
Hi! I can help you understand HR 5969. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline